Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

April 2015 Issue of The Ophthalmologist

Register to download

Register here to download any issue of The Ophthalmologist for FREE.


Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Articles featured in this issue

Business & Profession Professional Development

The Value of The List

| Mark Hillen

We run the Power List to contribute, not to be controversial.

Business & Profession Professional Development

3-D Printed Prosections

Inexpensive, high-resolution 3D printouts of orbital prosections can help ophthalmology trainees revisit basic anatomy

Subspecialties Cornea / Ocular Surface

Reducing Corneal Graft Rejection on a Very Small Scale

Nanoparticles deliver sustained corticosteroid levels to prevent corneal graft rejection

Subspecialties Cornea / Ocular Surface

Classifying Keratoconus – Classically

There’s still a place for retinoscopy in the diagnosis and staging of corneal ectasias

Subspecialties Imaging & Diagnostics

A Penny Pusher Model of Lens Growth

New research shows that lens epithelial cells proliferate along a narrow line, pushing older cells toward the equator and then the center of the lens

Business & Profession Cataract

Picketing Parliament

Ophthalmologists and other eye health stakeholders lobby UK Parliament to implement improved sight loss and eye health services

Subspecialties Retina

The BMJ Bevacizumab Brouhaha

Novartis “embarked on a campaign to undermine” the use of bevacizumab in wet AMD, a BMJ investigation alleges.

Subspecialties Cataract

Look How Far We’ve Come

We look at the last 50 years of Fight for Sight – the projects it has funded, and the discoveries its funding helped to achieve.

Business & Profession Professional Development

Freedom Fighter

Sitting Down With… David Pyott, Chairman of the Board and Chief Executive Officer of Allergan, Inc.

Subspecialties Cornea / Ocular Surface

Dry Eye Disease’s Diagnostic Challenge

| Sponsored by Santen Pharmaceuticals

The multifactorial nature of dry eye disease means that often, there’s a discordance between signs and symptoms, confounding diagnosis. Can things be improved?

Business & Profession Other

5 Things We Learned This Month:

Five Things We Learned This Month:

Other issues of 2015